- The 8 States Most Likely to Legalize Marijuana Next
- Behind Russia's Current Crisis: It's Not the Ruble, It's Putin
- Would you invest in the U.S. Postal Service?
- Why Jim Cramer Says it Could be Too Late to Enter the Stock Market Rally Now
- Apple (AAPL) Stock Declining Today Amid Allegations of Poor Working Conditions in China
Fund manager Martin Shkreli offers advice on how to avoid the next Oncothyreon blowup.
Investor Martin Shkreli believes Nektar's constipation drug is a bust and the stock is a good short.